24th Annual Scientific and Clinical Congress

Register Here

Exhibitors

WEDNESDAY, MAY 13

6:30 am - 6:30 pm Attendee Registration
12:30 pm - 6:30 pm CME Station Hours
8:00 am - 12:00 pm SPECIAL SESSION I
 

W11: Hot Topics in Thyroid Practice

Chair: Hossein Gharib, MD

Room: 101 DE
CME Code: 6135

 

W21: Diabetes Technology Update for Your Practice
Chair: George Grunberger, MD

Room: 102 AB
CME Code: 5096
 

W31: DXA for the Practicing Endocrinologist: What Every Clinician Needs to Know
Chair: Susan E. Williams, MD

Room: 101 B
CME Code: 7124
 

W41: Leadership Forum
Co-Chairs: Howard M. Lando, MD & Anne L. Leddy, MD
Speakers: Tara Hickey & Eric Martin

  • What Leadership Role Can We Play as Champions for Clinical Endocrinologists?
  • What is the Nature of Leadership Work Required for Example to Strengthen Membership and improve the Chapter Effectiveness?
  • What Personal Adaptations May be Required so That We Can More Effectively Lead Consequential Change?

Room: 101 A
CME Code: 1606

1:00 pm - 5:00 pm SPECIAL SESSION II
 

W12: The AACE Module and Tool Kit for Obesity Medicine
Chair: W. Timothy Garvey, MD

Room: 101 B
CME Code: 3467
 

W22: Challenging Topics in Pituitary and Adrenal Disorders
Co-Chairs: Richard J. Auchus, MD & Laurence Katznelson, MD

Room: 101 DE
CME Code: 8382
 

W32: 2015 Diabetes Update
Co-Chairs: Vivian A. Fonseca, MD & Etie S. Moghissi, MD

Room: 102 AB
CME Code: 2035
 

W42: Endocrinology in the Real World
Co-Chairs: Bill Law, Jr., MD & Katherine A. Roberts, MD

Room: 101 A
CME Code: 1122
1:00 pm - 5:30 pm

W52: AACE Maintenance of Certification and Mini-Board Review Course
Chair: Pauline M. Camacho, MD
Speakers: Elise M. Brett, MD, Pauline M. Camacho, MD, & Hossein Gharib, MD

  • To discuss recent updates on the endocrine certification process
  • To discuss ASAP 2014 Thyroid Module
  • To discuss ASAP 2014 Parathyroid & Bone Module

Room: 101 C
CME Code: 7892

5:30 pm - 7:45 pm

WSS1: LDL-C Reduction in the High-Risk Patient: How Low Should We Go?
Room: Omni Nashville - Legends Ballroom ABC
CME Code: 2454

THURSDAY, MAY 14

5:15 am - 7:30 am

TSS1: Overcoming Barriers in Diabetes Management with Individualized Treatment Strategies
Room: Omni Nashville - Legends Ballroom ABC
CME Code: 5456

6:30 am - 6:00 pm Attendee Registration
7:00 am - 6:00 pm CME Station Hours
9:45 am - 2:15 pm Exhibit Hall Hours
8:00 am - 8:15 am General Session Announcements
8:15 am - 9:00 am

TGS1: Bionic Pancreas
Moderator: R. Mack Harrell, MD
Speaker: Edward R. Damiano, MD
Room: BALLROOM A
CME Code: 1348

9:00 am - 9:45 am

TGS2: Neonatal Diabetes: Identification, Initial Treatment, and Transitioning the Parent
Moderator: Yehuda Handelsman, MD
Speaker: Siri A.W. Greeley, MD

Room: BALLROOM A

CME Code: 2924
9:45 am - 11:00 am Exhibit Hall Coffee Break
10:00 am - 10:45 am Product Theaters in the Exhibit Hall
11:00 am - 11:45 am

TGS3: Microarchitectural of Bone and its Clinical Relevance
Moderator: Pauline M. Camacho, MD
Speaker: John Paul Bilezikian, MD
Room: BALLROOM A
CME Code: 6520

11:45 am - 12:30 pm

TGS4: The Link Between Retinopathy and VEGF: The Journey from Discovery through Clinical Therapy
Moderator: Sandra L. Weber, MD
Speaker: Michael J. Tolentino, MD
Room: BALLROOM A
CME Code: 1764

12:30 pm - 2:15 pm President’s Welcome Box Lunch in Exhibit Hall
12:45 pm - 1:30 pm

Product Theaters in the Exhibit Hall

12:30 pm - 2:15 pm

Women of Endocrinology Luncheon: If I Knew Then, What I Know Now (non-CME)
Moderator: Etie S. Moghissi, MD
Speaker: Camille Lee, Senior Vice President, Diabetes Marketing for Novo Nordisk Inc.

2:15 pm - 3:15 pm Meet-the-Experts
 

SESSION I

 

T11: Of Hispanics and Metabolism: Understanding the Risk for Diabetes
Moderator: Donald A. Bergman, MD
Speaker: Jaime A. Davidson, MD
Room: 101 B
CME Code: 2502

 

T21: Testosterone Use: When and How; Testosterone Treatment in Young Males
Moderator: Elise M. Brett, MD
Speaker: Paul Turek, MD
Room: 104 ABC
CME Code: 4276

 

T31: Practicalities in the Use of Pharmacologic Agents
Moderator: Felice A. Caldarella, MD
Speaker: Caroline Apovian, MD
Room: 101 A
CME Code: 4366

 

T41: Thyroid Ultrasound Images
Moderator: Mark A. Lupo, MD
Speaker: Robert A. Levine, MD
Room: 103 ABC
CME Code: 3031

 

T51: Controversies in Osteoporosis Management
Moderator: Daniel L. Hurley, MD
Speaker: Felicia Cosman, MD
Room: 101 CDE
CME Code: 2749

 

T61: (Point/Counterpoint) Subclinical Hypothyroidism: Treat or Not
Moderator: Peter A. Singer, MD
Speaker Point: Paul W. Ladenson, MD
Speaker Counter: Jeffrey R. Garber, MD
Room: 104 DE
CME Code: 2533

 

T71: (Case Review) Challenging Lipid Cases
Moderator: David S. H. Bell, MD
Speaker: Lisa Tannock, MD
Room: 102 AB
CME Code: 3370

3:15 pm - 3:30 pm Coffee Break
3:30 pm - 4:30 pm

Meet-the-Expert

 

SESSION II

 

T12: Emerging Therapies and Technologies for the Treatment of Diabetes
Moderator: S. Sethu K. Reddy, MD
Speaker: Irl B. Hirsch, MD
Room: 104 ABC
CME Code: 9140

 

T22: Update on PCKS9 Inhibitors and New Therapies
Moderator: M. Kathleen Figaro, MD
Speaker: Evan A. Stein, MD
Room: 101 CDE
CME Code: 3961

 

T32: Challenges in Management of the Endocrine Patient: Transition of Care from Pediatric to Adult Endocrinology
Moderator: Rajib Bhattacharya, MD
Speaker: A. Jay Cohen, MD
Room: 101 A
CME Code: 8484

 

T42: The Nutritional Prevention and Reversal of Cardiovascular Disease-Fact or Fiction?
Moderator: Chris K. Guerin, MD
Speaker: Caldwell B. Esselstyn, Jr., MD
Room: 102 AB
CME Code: 5611

 

T52: The Mind’s Role in Obesity
Moderator: Michael A. Bush, MD
Speaker: Joshua P. Thaler, MD
Room: 104 DE
CME Code: 3053

 

T62: Ectopic ACTH: Diagnosis and Treatments
Moderator: Janet B. McGill, MD
Speaker: Maria Fleseriu, MD
Room: 101 B
CME Code: 2300

 

T72: (Case Review) Update on Pheochromocytoma and Paraganglioma: Implications for Clinical Practice
Moderator: Rachel Pessah-Pollack, MD
Speaker: Karel Pacak, MD
Room: 103 ABC
CME Code: 8408

4:45 pm - 5:45 pm

Meet-the-Experts
SESSION III

 

T13: Diabetes Transition from Pediatrics to Adulthood
Moderator: Dace L. Trence, MD
Speaker: Jennifer Raymond, MD
Room: 102 AB
CME Code: 6174

 

T23: Statin Intolerance: Statin Side-Effects?
Moderator: Richard A. Haas, MD
Speaker: Lisa Tannock, MD
Room: 101 CDE
CME Code: 4043

 

T33: Late-Effects in the Emerging Population of Childhood Cancer Survivors
Moderator: Vin Tangpricha, MD
Speaker: Sripriya Raman, MD
Room: 101 A
CME Code: 9536

 

T43: Ectopic ACTH: Diagnosis and Treatments
Moderator: Janet B. McGill, MD
Speaker: Maria Fleseriu, MD
Room: 101 B
CME Code: 1816

 

T53: Thyroid Ultrasound Images
Moderator: Mark A. Lupo, MD
Speaker: Robert A. Levine, MD
Room: 103 ABC
CME Code: 1868

 

T63: The Mind’s Role in Obesity
Moderator: Michael A. Bush, MD
Speaker: Joshua P. Thaler, MD
Room: 104 DE
CME Code: 1352

 

T73: (Case Review) Challenging Thyroid Cases
Moderator: Robert S. Zimmerman, MD
Speakers: Paul W. Ladenson, MD & Susan J. Mandel, MD
Room: 104 ABC
CME Code: 5848

6:00 pm - 7:00 pm

Chapter & International Receptions

7:30 pm - 9:45 pm

TSS3: Paradigm Shifts in Hypoparathyroidism: How New Insights in Epidemiology and Treatment are Changing the Standard of Care
Room: Omni Nashville - Legends Ballroom ABC
CME Code: 8313

7:30 pm - 9:45 pm

TSS4: Combination Therapy in Type 2 Diabetes Management: Charting Courses for Success
Room: Omni Nashville - Legends Ballroom EFG
CME Code: 4711

FRIDAY, MAY 15

5:15 am - 7:30 am

FSS1: Prevention and Management of Diabetic Retinopathy and Related Eye Disorders: Clarifying the Endocrinologist's Role
Room: Omni Nashville - Legends Ballroom ABC
CME Code: 4117

5:15 am - 7:30 am

FSS2: Applying the Fundamentals of Insulin Physiology to Modernize Exogenous Insulin Therapy: An Expert Panel Exchange and Interactive Town Hall Discussion
Room: Omni Nashville - Legends Ballroom EFG
CME Code: 3879

7:30 am - 5:30 pm

Attendee Registration

7:30 am - 6: 30 pm CME Station Hours
9:45 am - 2:15 pm Exhibit Hall Hours
8:00 am - 8:15 am General Session Announcements
8:15 am - 9:00 am

FGS1: Molecular Drivers for Fat Genesis and their Roles in Diabetes and Obesity
Moderator: Daniel Einhorn, MD
Speaker: Ronald Evans, PhD
Room: BALLROOM A
CME Code: 9031

9:00 am - 9:45 am

FGS2: Short-Term and Long-Term Impacts of Genetic Discovery on the Practice of Endocrinology
Moderator: Robert Rapaport, MD
Speaker: Joel Hirschhorn, MD
Room: BALLROOM A
CME Code: 6570

9:45 am - 11:00 am Exhibit Hall Coffee Break
10:00 am - 10:45 am Product Theaters in Exhibit Hall
11:00 am - 12:30 pm Mini Plenary Sessions
 

FGS3: Transcultural Endocrinology Symposium
Chair/Moderator: Jeffrey I. Mechanick, MD

Room: 101 CDE
CME Code: 6411
11:00 am - 11:45 am

FGS4: Oral Poster Presentations
Moderators: Edward S. Horton, MD & David S. Lieb, MD
Room: 103 ABC
CME Code: 1482

 

FGS5: Thyroid: The Year in Review
Moderator: Peter A. Singer, MD
Speaker: Susan J. Mandel, MD
Room: 104 ABC
CME Code: 2044

11:45 am - 12: 30 pm

FGS6: Late Breaking Clinical Trials (non-CME)
Moderators: Alan J. Garber, MD, Janet B. McGill, MD, & Vin Tangpricha, MD
Room: 104 ABC

 

FGS7: Oral Poster Presentations
Moderators: Edward S. Horton, MD & David C. Lieb, MD
Room: 103 ABC
CME Code: 9498

12:30 pm - 2:15 pm Exhibit Hall Break
12:45 pm - 1:30 pm Product Theaters in Exhibit Hall
2:15 pm - 5:00pm In-Depth Symposia
 

F11: Transition from Childhood to Adulthood
Chair: Robert Rapaport, MD

Room: 101 A
CME Code: 9762
 

F21: Advances in Thyroid Cancer
Chair: Hossein Gharib, MD

Room: 104 ABC
CME Code: 7689
 

F31: Updates on Osteoporosis and Metabolic Bone Disease
Chair: Pauline M. Camacho, MD

Room: 101 CDE
CME Code: 5982
 

F41: Assessing the Benefits and Risks of Testosterone Therapy in Men and Women
Co-Chairs: Paresh Dandona, MD & Neil F. Goodman, MD

Room: 104 DE
CME Code: 7112

 

F51: Novel Therapeutic Approaches to Type 2 Diabetes and Complications
Chair: Robert R. Henry, MD

Room: 103 ABC
CME Code: 9927

 

F61: Lipid Guidelines: Can We Identify the Risk, but Not the Numbers?
Chair: Kathleen L. Wyne, MD

Room: 102 AB
CME Code: 4819

 

F71: AACE/SMNE Pan American Symposia: Lifestyle, Metabolic Disorders and Cancer
Co-Chairs: Myriam Allende-Vigo, MD

Room: 101 B
CME Code: 6499

5:00 pm - 6:30 pm Exhibit Hall Wine & Cheese Reception
7:00 pm - 9:15 pm

FSS3: Continuous Coverage and Clinical Application of Real-Time CGM: Pathway to Improved Outcomes and Reduced Cost
Room: Omni Nashville - Legends Ballroom ABC
CME Code: 7276

7:00 pm - 9:15 pm

FSS4: Managing Obesity in 2015: Setting the Framework and Assessing All of the Options
Room: Omni Nashville - Legends Ballroom EFG
CME Code: 6985

SATURDAY, MAY 16

7:30 am - 5:00 pm Attendee Registration
7:30 am - 6:00 pm CME Station Hours
9:45 am - 1:00 pm Exhibit Hall Hours
8:00 am - 8:15 am General Session Announcements
8:15 am - 9:00 am

SGS1: The Three Pathways of Translational Research: Diabetes and a Personal Experience
Moderator: Jeffrey I. Mechanick, MD
Speaker: Valentin Fuster, MD
Room: BALLROOM A
CME Code: 6637

9:00 am - 9:45 am

SGS2: Deletions and Mutations in Growth Hormone- Receptor (Laron Syndrome): Genetic, Biological, and Clinical Aspects
Moderator: Jaime A. Davidson, MD
Speaker: Zvi Laron, MD
Room: BALLROOM A
CME Code: 9226

9:45 am - 11:00 am Exhibit Hall Coffee Break
10:00 am - 10:45 am Product Theaters in Exhibit Hall
11:00 am - 11:45 am

SGS3: Metformin: Its Non-Glycemic Effects and Cardiovascular Risk Reduction
Moderator: Anne L. Leddy, MD
Speaker: John M. Miles, MD
Room: BALLROOM A
CME Code: 5263

11:45 am - 12:30 pm

SGS4: Disordered Growth Hormone Secretion in HIV: Mechanisms and Novel Therapeutic Strategies
Moderator: Felice A. Caldarella, MD
Speaker: Steven K. Grinspoon, MD
Room: BALLROOM A
CME Code: 6442

12:30 pm - 2:15 pm AACE Annual Business Meeting Luncheon
2:15 pm - 3:15 pm

Meet-the-Expert
SESSION I

 

S11: Year in Diabetes
Moderator: Etie S. Moghissi, MD
Speaker: Claresa S. Levetan, MD
Room: 104 ABC
CME Code: 3747

 

S21: FGF: New Guy on the Scene
Moderator: Sunil Wimalawansa, MD
Speaker: Bryan Kestenbaum, MD
Room: 101 A
CME Code: 4062

 

S31: Neurohumoral Syndromes
Moderator: Derek LeRoith, MD
Speaker: Aaron I. Vinik, MD
Room: 101 B
CME Code: 1351

 

S41: Hyperandrogenic Anovulation
Moderator: W. Reid Litchfield, MD
Speaker: Margaret E. Wierman, MD
Room: 103 ABC
CME Code: 8295

 

S51: The Year in Pituitary Disease
Moderator: Ved V. Gossain, MD
Speaker: Mark E. Molitch, MD
Room: 101 CDE
CME Code: 5747

 

S61: (Point/Counterpoint) To Use or Not Molecular Markers
Moderator: Jonathan D. Leffert, MD
Speaker Point: Bryan McIver, MD
Speaker Counter: Mark A. Lupo, MD
Room: 102 AB
CME Code: 4172

 

S71: (Case Review) Thyroid Cases: Weird and the Not So Unusual
Moderator: Farhad Zangeneh, MD
Speaker: Jeffrey R. Garber, MD
Room: 104 DE
CME Code: 4888

3:15 pm - 3:30 pm Coffee Break
3:30 pm - 4:30 pm

Meet-the-Experts
SESSION II

 

S12: Update on the Impact of Sleep Disturbances in Metabolic Disorders
Moderator: Joseph Aloi, MD
Speaker: Eve Van Cauter, MD
Room: 101 CDE
CME Code: 2049

 

S22: ICD-10
Moderator: Katherine A. Roberts, MD
Speaker: Todd W. Frieze, MD
Room: 104 DE
CME Code: 7338

 

S32: Lipidystrophy
Moderator: Felice A. Caldarella, MD
Speaker: Savitha Subramanian, MD
Room: 102 AB
CME Code: 9000

 

S42: PCOS in Adolescent Girls: Diagnosis and Management
Moderator: Sripriya Raman, MD
Speaker: Selma F. Witchel, MD
Room: 104 ABC
CME Code: 7621

 

S52: Treatment of Progressive Thyroid Cancer
Moderator: Gregory Randolph, MD
Speaker: Steven I. Sherman, MD
Room: 103 ABC
CME Code: 5732

 

S62: Neurohumoral Syndromes
Moderator: Derek LeRoith, MD
Speaker: Aaron I. Vinik, MD
Room: 101 B
CME Code: 2930

 

S72: Preventing Type 2 Diabetes in Latino Youth: translational Science to Clinical Relevance
Moderator: Craig Wierum, MD
Speaker: Gabriel Q. Shaibi, MD
Room: 101 A
CME Code: 5415

4:45 pm- 5:45 pm SESSION III
  Meet-the-Experts
 

S13: Normocalcemic Hyperparathyroidism
Moderator: Gary W. Edelson, MD
Speaker: Shonni J. Silverberg, MD
Room: 104 ABC
CME Code: 3027

 

S23: Endocrine Jeopardy
Moderator: Ricardo Correa, MD
Speaker: Cheryl Rosenfeld, MD
Room: 104 DE
CME Code: 9598

 

S33: Update on the Impact of Sleep Disturbances in Metabolic Disorders
Moderator: Joseph Aloi, MD
Speaker: Eve Van Cauter, MD
Room: 101 CDE
CME Code: 2554

 

S43: Subclinical Cushing’s
Moderator: Donald W. Richardson, MD
Speaker: John D. Carmichael, MD
Room: 102 AB
CME Code: 5477

 

S53: Neutroceuticals
Moderator: Shashank R. Joshi, MD
Speaker: Kenneth D. Burman, MD
Room: 101 A
CME Code: 7915

 

S63: Treatment of Progressive Thyroid Cancer
Moderator: Gregory Randolph, MD
Speaker: Steven I. Sherman, MD
Room: 103 ABC
CME Code: 9199

 

S73: (Point/Counterpoint) Data on Ethnic Disparities in Diabetes Prevalence
Moderator: Gary A. Trager, MD
Speaker Point: Elizabeth Selvin, MD
Speaker Counter: Samuel Dagogo-Jack, MD
Room: 101 B
CME Code: 7635

6:30 pm ACE Convocation
7:30 pm President’s Gala

SUNDAY, MAY 17

7:00 am - 11:30 am Attendee Registration
7:30 am - 12:00 pm CME Station Hours
7:00 am - 8:00 am

Breakfast
Room: BALLROOM A

8:00 am - 8:15 am

General Session Announcements

8:00 am - 11:00 am

Oral Presentations on Planning Research in Diabetes (PRIDE) F(non-CME)

Room: 108
8:15 am - 9:00 am

SGS5: AACE/AAES Joint Review of Cases on Hyperparathyroidism

Moderator: Nancy D. Perrier, MD Speakers: Mira Milas, MD & Shonni J. Silverberg, MD
Room: BALLROOM A
CME Code: 5183

9:15 am - 10:00 am

SGS6: AACE/AAES Joint Review of Cases on Thyroid Cancer Management

Moderator: Carmen C. Solorzano, MD
Speakers: Gregory Randolph, MD & R. Michael Tuttle, MD
Room: BALLROOM A
CME Code: 9932

10:15 am - 11:00 am

SGS7: AACE/AAES Joint Review of Cases on Adrenal Nodules

Moderator: Gerard Doherty, MD
Speakers: Clive S. Grant, MD & Gary D. Hammer, MD
Room: BALLROOM A
CME Code: 5590

11:00 am - 11:15 am Final Announcements; Adjournment

AACE Impact Graphics™
When medicine and creativity combine, AACE Impact Graphics is there to craft something truly remarkable! Specializing in medical graphic design, AACE Impact Graphics is a nationally-recognized design firm with an impressive portfolio of websites, company branding, publications, marketing collateral and more. Stop by the AACE Impact Graphics booth, located in the AACE booth, to learn more about our design services! Visit us at http://www.aaceimpactgraphics.com

522

AACE Membership Services
Located in the center of the Exhibit Hall, the AACE Membership Services booth is the place to visit for information on all AACE programs and resources. You’ll find AACE Educational Activities, Publications, Legislative, Socioeconomic, and Patient Resources all conveniently located together. Stop by to join or renew your membership and learn about the many exciting activities and resources AACE offers. Knowledgeable AACE staff will be on hand to assist you so come with questions, relax in our comfortable seating area, tell us where you are from on our oversized map, or just say hello. All visitors to the AACE Booth will be awarded with 50 bonus AMP points!

522

Abbott Diabetes Care

332

AbbVie
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. www.abbvie.com

614

Alexion Pharmaceuticals

206

Amarin Pharma Inc.
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is a highly-pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information visit www.amarincorp.com.

240

AMEND USA
AMEND USA is run by patients, for patients, to inform and support anyone affected by Multiple Endocrine Neoplasia (MEN) types 1, 2, and 3, and assorted endocrine syndromes and tumors. We are here to break the isolation so often felt by those with these rare diseases. http://www.amendusa.org

249

American Medical Systems (AMS)
American Medical Systems (AMS) is a diversified supplier of medical devices and procedures to treat benign prostatic hyperplasia (BPH), incontinence, sexual dysfunction, and other pelvic disorders in men and women. AMS continues to develop new therapies to restore bodily functions enabling people to regain control of their lives.

147

American Society of Endocrine Physician Assistants
The American Society of Endocrine Physician Assistants (ASEPA) is a professional medical organization dedicated to Endocrine education and the advancement of PAs in Endocrinology to provide increased access to quality patient care. Endocrine-pa.com

449

American Thyroid Association
The American Thyroid Association (ATA) is the leading organization devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health. ATA delivers its mission through the publication of monthly journals, the annual scientific meeting, research grants, public/patient educational programs, and guidelines for clinical management of thyroid disease. Visit www.thyroid.org for additional information.

347

Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.www.amgen.com

438

Asante Snap

646

AstraZeneca

512, 633

BD Diabetes Care
BD Pen Needles and Insulin Syringes support earlier initiation and better adherence to therapies with leading technology designed to improve injection comfort, convenience and safety, helping diabetes patients live healthier lives. Visit: www.bd.com/us/diabetes

236

Bio-Rad Laboratories

105

Blood Sugar Basics: Get To Your Goals
Blood Sugar Basics is an educational program designed to help people with type 2 diabetes work with their doctor to set and reach an A1C goal that is right for them. The program was developed by the American College of Endocrinology with support from Merck.

603

Boehringer Ingelheim Pharmaceuticals, Inc.
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in diabetes that centers on compounds representing several of the largest diabetes treatment classes. This alliance leverages the strengths of two of the world’s leading pharmaceutical companies. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs.
Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

300

CBL Path
CBLPath is a leading thyroid pathology and molecular diagnostics laboratory.  Our cytopathologists interpret over 40,000 thyroid FNAs annually with an exceptionally low indeterminate rate.  We’re the only commercial lab to offer ThyroSeq v.2®, an innovative next generation sequencing assay for indeterminate thyroid FNAs, featuring high NPV, PPV, sensitivity and specificity. www.cblpath.com

101

Charleston Area Medical Center
Charleston Area Medical Center, Inc. is a non-profit, 900-bed, regional referral center with three Charleston locations: General Hospital, Memorial Hospital and Women and Children's Hospital and a fourth hospital located in Hurricane, West Virginia. The medical center is located in the state capitol of West Virginia. Website is: www.camc.org

144

Clinical Care Options
Clinical Care Options, LLC, is the leader in the development of innovative educational technology platforms that integrate all levels of medical education. CCO is dedicated to improving patient care by providing superior-quality, clinical knowledge and relevant educational content as delivered through its innovative online platforms, which provide comprehensive information solutions. www.clinicaloptions.com

446

ContextMedia:Health
In today's medical practice, patient satisfaction is vital. ContextMedia:Health's Waiting Room TV system and Exam Room tablets engage patients where and when they take action. Our award winning media turns wait-time into an informative experience. Please visit us at: www.contextmediahealth.com

341

Corcept Therapeutics
Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders. Its first FDA-approved medication, Korlym, is a first generation competitive GR antagonist, which competitively blocks the glucocorticoid receptor (GR), thereby inhibiting the effects of excess cortisol in patients with Cushing’s syndrome. Since 2012, Korlym is available as a once-daily oral treatment of hyperglycemia secondary to endogenous Cushing’s syndrome in adult patients with glucose intolerance or T2DM who have failed surgery or are not candidates for surgery. www.corcept.com www.corcept.com

645

Cornerstone Wellness
Cornerstone Wellness is revolutionary evidence based, comprehensive program that empowers physicians to cure the underlying cause of metabolic syndrome and diabetes.  This physician-developed program is easily installed into any Endocrinology practice, requires no additional staff, very little physician time and will increase practice revenue significantly.  Website www.cornerstonewellness.md

644

Dexcom, Inc.

506

eClinicalWorks
eClinicalWorks offers ambulatory clinical solutions consisting of EMR/PM software, patient portals and a community health records application. With more than 100,000+ physicians and 600,000+ users across all 50 states using its solutions, customers include physician practices, out-patient departments of hospitals, health centers, departments of health and convenient care clinics. http://www.eclinicalworks.com/

 

544

Eisai, Inc.
At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer’s disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at www.eisai.com/US.
Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina. Eisai’s global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs.

109 & 244

Endocrine Society

344

EndocrineWeb.com
EndocrineWeb.com is one of the largest and most visited websites exclusively devoted to endocrine disorders, diagnosis and treatment. The site provides exceptional resources for professionals as well as consumers seeking trustworthy patient education. EndocrineWeb.com is owned by Vertical Health, LLC, one of the fastest growing online medical media companies.

248

Ethicon
Bariatric & Metabolic Surgery has been shown to provide significant weight loss and improvement in obesity-related diseases such as T2DM. Ethicon, Inc. is a developer and manufacturer of surgical technologies used in Bariatric & Metabolic Surgery. Ethicon, Inc. is committed to offering healthcare professionals a connection to educational tools and clinical information to aid in the treatment of obesity and obesity-related diseases. Ethicon, Inc. is part of the Johnson & Johnson family of companies. Ethicon 4545 Creek Rd, Cincinnati, OH 45242 Website: www.ethicon.com Phone: 877-ETHICON (384-4266)

504

ForaCare
ForaCare, an international brand dedicated to develop, design and market innovative health monitoring products and TeleHealth solutions to bring chronic disease management to a whole new level. We provide a complete health management platform including wireless medical devices, communication hubs and much more! Link: www.foracare.com 

117

GE Healthcare

245

Genzyme
Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. Visit www.genzyme.com.

232 & 348

GlaxoSmithKline
GlaxoSmithKline is a leading research-based pharmaceutical company with a powerful
combination of skills to discover and deliver innovative medicines.  We offer a number of program resources to support effective health management strategies and improve patient care.  Please visit our exhibit to learn more about our products and resources. www.gsk.com

134

Graves’ Disease & Thyroid Foundation
The Graves’ Disease and Thyroid Foundation provides help and hope to patients with Graves' disease, thyroid eye disease, Hashimoto’s thyroiditis, and other thyroid-related disorders.  We provide credible, evidence-based information and support via phone, web, e-mail, social media, local support groups, and national educational event. http://gdatf.org/

447

Hawaiian Moon

450

Health Monitor Network
Health Monitor Network is America’s leading patient engagement provider, and exclusive patient education partner of AANP. In addition to your FREE AACE-reviewed Diabetes Health Monitor Magazine and the Patient Guide to Diabetes, we provide websites, digital tablets, exam room digital touchscreens and posters, patient guides, apps, Community Health Ambassadors and more to help keep patients and providers informed and engaged. Stop by our booth and let us show you what we have to offer, all FREE to you and your patients.

451

Ideal Protein of America
Ideal Protein is a supervised, four-phase VLCD weight loss method utilizing foods of highly bio-available amino acids combined with lowered carbohydrate and fat intake. This is not a high protein diet.

719

Impeto Medical

333

Insulet Corporation

715

Interpace Diagnostics
Interpace Diagnostics’ mission is to improve patient care through personalized medicine and molecular diagnostic tests. Our CLIA-certified and CAP-accredited laboratories bring high-clinical value tests to market. Built on a foundation of rigorous science and utilization of the latest technology, we help inform the patient management decisions physicians make every day.

238

IPSEN Biopharmaceuticals, Inc.

608

Janssen Pharmaceuticals, Inc.

312

Lilly USA, LLC
Lilly has been a leader in diabetes care since 1923 when we introduced the world’s first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio, and a commitment to providing real solutions.

300

Livliga | Elegant Portion Control
Livliga is easy-to-use, elegant, affordable and patented portion control tableware, which incorporates the psychology of eating for a healthier lifestyle. Doctor & RD/Nutritionist approved. New! LivSpoons – serving spoons with measurements

234

Medical Review Institute of America
MRIoA, a nationally recognized IRO, currently works with some of the nation’s largest Health and PBM carriers. The need for external specialty matched physician review is growing. Changes to healthcare laws and state specific requirements for fully insured lines of business; have provided MRIoA the opportunity to expand our specialty panel. www.mrioa.com

601

Medtronic
The Diabetes Group at Medtronic (www.medtronicdiabetes.com) is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health

500

Merck

600

Metabolon, Inc.
Metabolon, Inc. is the global leader in metabolomics – a powerful phenotyping technology for assessing health. Its platforms advance biomarker discoveries, diagnostic tests, including Quantose IR™ and Quantose IGT™ for prediabetes, and breakthroughs in personalized medicine. Founded in 2000, Metabolon is based in Research Triangle Park, NC. Learn more at www.metabolon.com.

745

Novartis Pharmaceuticals

103

Novo Nordisk
Novo Nordisk is a global health care company with nearly a century of innovation and achievement in diabetes care. United in our passion for Changing Diabetes®, Novo Nordisk works every day to fight the diabetes pandemic and fulfill patient and health care provider needs. To learn more, visit NovoNordisk-US.com.

212

Novo Nordisk
As a world leader in therapeutic proteins and specialized health care, Novo Nordisk does more than produce medicines. We work to close the gap between the number of people who need care and those who receive it, and help improve access to adequate health care for people with chronic conditions.
Website: http://novonordisk-us.com

432

Novo Nordisk
As a world leader in therapeutic proteins and specialized health care, Novo Nordisk does more than produce medicines. We work to close the gap between the number of people who need care and those who receive it, and help improve access to adequate health care for people with chronic conditions.
Website: http://novonordisk-us.com

638

Optovue, Inc.

445

Otto Trading, Inc.

250

Outpatient Pathology Associates

337

Pikeville Medical Center
In its 90th year, Pikeville Medical Center is a 261-bed facility and offers more than 400 services, including every major specialty and most subspecialties. The nation's only repeat winner of National Hospital of the Year, PMC is dedicated to providing quality regional health care in a Christian environment.

251

Ranbaxy Laboratories

545

Riverside Health System
Riverside Medical Group (RMG)is a 500+ provider multi-specialty clinical team that is the heart of one of America’s strongest healthcare delivery organizations.  Riverside Health System (RHS) has been shaped by the integration of strong, engaged physicians at multiple levels and in pivotal positions throughout the organization. Link: http://www.riversideonline.com

339

Robard Corporation
Providing weight loss services for your patients with diabetes helps you combat the cause of the disease, achieve successful patient outcomes and greater profits. Robard Corporation provides all the tools and support you need to start and operate your medical weight loss program. Visit us at booth 119. www.robard.com, 800.222.9201.

119

Samsung Electronics America
Samsung Electronics has contributed to the digital revolution through products that encompass innovative technologies, original designs, convenience and customer values, and has always been a leader of such revolution. By branching out into the medical equipment industry, Samsung aims to become a global leader as a healthcare company.

439

Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi, 55 Corporate Drive, Bridgewater, NJ 08807 www.sanofi.us

100

Sanofi-Regeneron
Sanofi, a global healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients’ needs. Regeneron, a leading biopharmaceutical company, discovers, develops, manufactures, and commercializes biologic medicines for serious medical conditions. Since 2007, Sanofi and Regeneron have collaborated to develop and commercialize fully human monoclonal antibodies utilizing proprietary technologies.

114

Shire
Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology. Please visit www.shire.com www.npsp.com.

108

St. Peter’s Health Partners

350

Stanbio An EKF diagnostics Company

345

Takeda Pharmaceuticals U.S.A., Inc

550

Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the t:flex™ Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California. www.tandemdiabetes.com

607

Thyroid Cancer Care Collaborative, (TCCC)
The Thyroid Cancer Care Collaborative (TCCC) is an online HIPAA compliant application allowing patients and all doctors involved in the patient's care to track and share thyroid cancer treatment data.  The application is free of charge and is helping to streamline and standardize communication and quality of care.  www.thyroidccc.org

605

Valeritas, Inc.
Valeritas develops and commercializes innovative treatment solutions with an initial focus on Type 2 diabetes. Headlining Valeritas’ portfolio is the V-Go® Insulin Delivery Device, which is simple, convenient, and easy to use and provides a continuous preset basal rate of insulin for 24 hours plus on-demand bolus dosing.

441

Veracyte
Veracyte, Inc. develops the Afirma® Thyroid FNA Analysis, a comprehensive thyroid nodule management solution. Afirma integrates high-volume, thyroid-specialized cytopathology and genomic science to help doctors improve patient care by reducing the number of thyroid surgeries, minimizing patient anxiety and healthcare costs, and facilitating a decision about surgery in one patient visit. The centerpiece of Afirma is its Gene Expression Classifier, a genomic test that clarifies indeterminate thyroid nodule cytopathology results as benign or suspicious for cancer. Afirma has been validated in numerous peer-reviewed studies and is recommended in several key practice guidelines. Additionally, Afirma is now covered by most major health insurance plans in addition to Medicare.

200

VIVUS, Inc.
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Qsymia is approved in the U.S. and is indicated as an adjunct to diet and exercise for chronic weight management in adults who are obese or overweight with at least one weight-related comorbidity.

338

Welch Allyn
The Welch Allyn® RetinaVue™ Network is a turnkey solution enabling primary care providers to perform Diabetic Retinal Exams in their clinics. RetinaVue’s fast, simple, three-step process is guaranteed to achieve 5 STAR compliance within 12 months, preserving patient vision while also increasing quality metrics and revenue in your practice. www.welchallyn.com

145

Yale Pathology Labs
Yale Pathology Labs is a comprehensive anatomic pathology service with the internationally recognized teaching and research expertise of Yale University School of Medicine. When you choose to use Yale Pathology Labs you will find an exceptional medical community pooling its technical resources and its vast array of human talent to resolve the diagnostic question at hand. Visit us at www.uyalepathlabs.org

444